Table 3. Multivariate Cox regression analysis to adjust the risk factors for tumor progression.
| Prognostic factor | β | HR | 95% CI | P |
|---|---|---|---|---|
| Histological subtype | ||||
| Non adeno vs Adeno | 1.057 | 2.88 | 1.205–6.880 | 0.017 |
| pTNM stage | ||||
| III vs I/II | 0.386 | 1.47 | 0.627–3.452 | 0.375 |
| Anti-ENO1 level | ||||
| <12% vs ≥12% | 1.168 | 3.22 | 1.302–7.944 | 0.011 |
| Tumor size | ||||
| >5 cm3 vs ≤5 cm3 | 1.194 | 3.30 | 1.235–8.826 | 0.017 |
The median tumor volume was 5 cm3. The median increase of anti-ENO1 Ab was 12%.
Adeno, adenocarcinoma; Non adeno, non-adenocarcinoma; β, regression coefficient; CI, confidence interval; HR, hazard ratio.